Asthma: open trials in Argentina

• NCT07359846

  A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

  Trial Treatment · Phase 3 · Generate Biomedicines

  Research Site 67, Buenos Aires · Research Site 120, Buenos Aires · Research Site 103, Buenos Aires · Research Site 33, Ciudad Autónoma de Buenos Aires · Research Site 87, Ciudad Autónoma de Buenos Aires · Research Site 79, Ciudad Autónoma de Buenos Aires · Research Site 31, Ciudad Autónoma de Buenos Aires · Research Site 92, Ciudad Autónoma de Buenos Aires · Research Site 81, Concepción del Uruguay · Research Site 116, Mar del Plata · Research Site 94, Mar del Plata · Research Site 80, Mendoza · Research Site 119, Rosario · Research Site 98, Rosario · Research Site 100, San Miguel de Tucumán · Research Site 113, San Miguel de Tucumán · Research Site 107, San Salvador · Research Site 125, Santa Fe

  Registry updated 2026-11-03

• NCT07746687

  A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

  Trial Treatment · Phase 2 · Janssen Research & Development, LLC

  INAER - Investigacion en Alergias y Enfermedades Respiratorias, Buenos Aires · Instituto de Medicina Respiratoria - Imer, Córdoba · Fundacion Scherbovsky, Mendoza · Instituto De Especialidades De La Salud SRL, Rosario · IBAMEDICA Propiedad de IBA Santa Fe S.A.S, Santa Fe

  Registry updated 2026-11-03

• NCT06932263

  Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

  Trial Treatment · Phase 2 · AstraZeneca

  Research Site, CABA · Research Site, Ciudad de Buenos Aires · Research Site, La Plata · Research Site, Mendoza · Research Site, Rosario · Research Site, San Miguel de Tucumán

  Registry updated 2026-10-30

• NCT07444567

  Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  Trial Treatment · Phase 3 · AstraZeneca

  Research Site, Buenos Aires · Research Site, Florida · Research Site, Lobos · Research Site, Mar del Plata · Research Site, Mendoza · Research Site, Rosario · Research Site, San Juan Bautista

  Registry updated 2026-10-27

• NCT07219173

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  Trial Treatment · Phase 2 · Eli Lilly and Company

  Consultorios Médicos, Organización del Buen Ayre S.R.L., Buenos Aires · Fundacion Respirar, Buenos Aires · Centro de Investigaciones Metabólicas (CINME), Buenos Aires · IDIM - Instituto de Investigaciones Metabólicas, Ciudad de Buenos Aires · Instituto de Asma, Alergia y Enfermedades Respiratorias, Corrientes · Centro de Investigaciones Clínicas Baigorria, Granadero Baigorria · Instituto de Investigaciones Clinicas Mar del Plata, Mar del Plata · Instituto Médico Río Cuarto, Río Cuarto · ABC Instituto de Diagnóstico, Rosario · Ibamedica, Santa Fe

  Registry updated 2026-10-22

• NCT07120503

  Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

  Trial Treatment · Phase 2 · Windward Bio

  WB Contracted Clinical Research Site, Buenos Aires · WB Contracted Clinical Research Site, Córdoba · WB Contracted Clinical Research Site, Paraná · WB Contracted Clinical Research Site, Rosario · WB Contracted Clinical Research Site, San Miguel de Tucumán · WB Contracted Clinical Research Site, Santa Fe

  Registry updated 2026-10-21

• NCT05562466

  A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, CABA · Novartis Investigative Site, Mendoza · Novartis Investigative Site, Rosario

  Registry updated 2026-10-15

• NCT05776927

  A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Rosario

  Registry updated 2026-10-15

• NCT06023589

  A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

  Trial Treatment · Phase 3 · AstraZeneca

  Research Site, Buenos Aires · Research Site, CABA · Research Site, Florida · Research Site, Lanus · Research Site, Lobos · Research Site, Mendoza · Research Site, Quilmes · Research Site, Rosario

  Registry updated 2026-10-13

• NCT06977581

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  Trial Treatment · Phase 2 · Pfizer

  Centro de Investigaciones Metabólicas (CINME), Buenos Aires · Fundacion Cidea, Buenos Aires · Fundacion Respirar, Ciudad Autonoma de Buenos Aires · Instituto Ave Pulmo, Mar del Plata · Instituto de Salud Respiratoria, Mendoza · Fundacion Scherbovsky, Mendoza · Instituto Especialidades de la Salud Rosario, Rosario · Investigaciones en Patologias Respiratorias, San Miguel de Tucumán

  Registry updated 2026-10-13

• NCT07245576

  Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis

  Research · AstraZeneca

  Research Site, Buenos Aires · Research Site, Medoza

  Registry updated 2026-10-13

• NCT07525375

  A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

  Trial Treatment · Phase 2 · AstraZeneca

  Research Site, Buenos Aires · Research Site, CABA · Research Site, Lanús Este · Research Site, La Plata · Research Site, Lobos · Research Site, Mar del Plata · Research Site, Mendoza · Research Site, Rosario · Research Site, San Juan Bautista · Research Site, Santa Fe

  Registry updated 2026-10-13

• NCT07323654

  A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

  Trial Treatment · Phase 2 · Kymera Therapeutics, Inc.

  Kymera Investigative Site, Buenos Aires · Kymera Investigative Site, Concepción del Uruguay · Kymera Investigative Site, Lobos · Kymera Investigative Site, Mar del Plata · Kymera Investigative Site, Quilmes · Kymera Investigative Site, Rosario · Kymera Investigative Site, San Miguel de Tucumán

  Registry updated 2026-10-06

• NCT05757102

  A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  Trial Treatment · Phase 3 · GlaxoSmithKline

  GSK Investigational Site, Buenos Aires · GSK Investigational Site, Córdoba · GSK Investigational Site, Lanus · GSK Investigational Site, Lobos · GSK Investigational Site, Lujan de Cuyo · GSK Investigational Site, Mar del Plata · GSK Investigational Site, Rosario · GSK Investigational Site, Rosario Provincia de Santa FE · GSK Investigational Site, San Miguel de Tucumán · GSK Investigational Site, Santa Fe

  Registry updated 2026-09-30

• NCT07645248

  A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

  Trial Treatment · Phase 3 · GlaxoSmithKline

  GSK Investigational Site, Buenos Aires · GSK Investigational Site, Ciudad Autonoma de Buenos Aire

  Registry updated 2026-09-30

• NCT06609239

  Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma

  Trial Treatment · Phase 2 · Sanofi

  Investigational Site Number : 0320007, Berazategui · Investigational Site Number : 0320004, Buenos Aires · Investigational Site Number : 0320005, Buenos Aires · Investigational Site Number : 0320001, Buenos Aires · Investigational Site Number : 0320011, Buenos Aires · Investigational Site Number : 0320012, Buenos Aires · Investigational Site Number : 0320003, La Plata, Buenos Aires · Investigational Site Number : 0320013, Lobos · Investigational Site Number : 0320015, Mendoza · Investigational Site Number : 0320009, Mendoza · Investigational Site Number : 0320002, Rosario · Investigational Site Number : 0320006, Rosario · Investigational Site Number : 0320020, Rosario · Investigational Site Number : 0320008, San Miguel de Tucumán · Investigational Site Number : 0320010, Santa Fe

  Registry updated 2026-09-21

• NCT06191315

  Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 0320002, Buenos Aires · Investigational Site Number : 0320001, Buenos Aires · Investigational Site Number : 0320008, Buenos Aires · Investigational Site Number : 0320003, Buenos Aires · Investigational Site Number : 0320006, Córdoba · Investigational Site Number : 0320009, Corrientes · Investigational Site Number : 0320004, Mendoza · Investigational Site Number : 0320005, Rosario

  Registry updated 2026-08-13

• NCT07301736

  Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

  Trial Treatment · Phase 2 · Chiesi Farmaceutici S.p.A.

  Centro Medico de Enfermedades Respiratorias_Site n. 032002, Buenos Aires · Asociación de Fomento y Sala de Primeros Auxilios "Alberto Mignaburu"_Site n. 032018, Buenos Aires · Centro Medico Arsema_Site n. 032003, Buenos Aires · Centro de Investigaciones Médicas Mar del Plata_Site n. 032019, Buenos Aires · Hospital Británico de Buenos Aires_Site n. 032029, Buenos Aires · Centro Medico Respire_Site n. 032014, Buenos Aires · Fundacion CIDEA_Site n. 032009, Buenos Aires · Fundación Respirar Salud_Site n. 032004, Ciudad Autonoma de Buenos Aire · CARE - Centro de Alergia y Enfermedades Respiratorias_Site n. 032028, Ciudad Autonoma de Buenos Aire · Centro de Investigaciones Metabólicas (CINME)_Site n. 032025, Ciudad Autonoma de Buenos Aire · Centro de Medicina Respiratoria - Concepcion del Uruguay_Site n. 032015, Ciudad Autonoma de Buenos Aire · Consultorio Medico Dra. Rivera_Site n. 032012, Ciudad Autonoma de Buenos Aire · Instituto de Medicina Respiratoria (IMER) - Cordoba_Site n. 032023, Córdoba · CePIR_Site n. 032021, La Plata · Fundacion Scherbovsky_Site n. 032013, Mendoza · Instituto Medico INSARES SA_Site n. 032005, Mendoza · Cimro Consultorios Medicos - Centro de Investigacion_Site n. 032006, Mendoza · Centro Respiratorio Quilmes_Site n. 032007, Quilmes · Instituto de Especialidades de la Salud Rosario_Site n. 032020, Rosario · Fundacion Innovaciencia_Site n. 032017, Rosario · Fundacion Grupo Colaborativo Rosario_Site n. 032010, Rosario · Instituto Medico de la Fundacion de Estudios Clínicos_Site n. 032001, Rosario · Instituto De Enfermedades Respiratorias E Investigacion Medica (IERIM)_Site n. 032011, San Juan Bautista · Investigaciones en Patologias Respiratorias_Site n. 032022, San Miguel de Tucumán · Clinica Mayo de UMCB SRL_Site n. 032026, San Miguel de Tucumán · Centro Modelo de Cardiologia SRL_Site n. 032016, San Miguel de Tucumán · IBAMEDICA_Site n. 032008, Santa Fe

  Registry updated 2026-06-25

• NCT07348302

  Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

  Trial Treatment · Phase 3 · Inmunotek S.L.

  Hospital Italiano de Buenos Aires, Buenos Aires · Centro de Educación Medica de Investigaciones Clinicas "Norberto Quirno" (CEMIC), Buenos Aires · Fundacion Cidea, Buenos Aires · Centro Médico Vitae, Nueve de Julio · Centro Respiratorio Infantil, Rosario · Centro de Investigaciones Clínicas - Instituto de Especialidades de la Salud Rosario, Rosario

  Registry updated 2026-01-16

• NCT05641272

  Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract

  Trial Treatment · Phase 2/3 · Inmunotek S.L.

  Fundacion Cidea, Buenos Aires

  Registry updated 2023-10-23

All Asthma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error